Johan Drott
Chief Executive Officer at Respiratorius AB
Johan Drott active positions
Companies | Position | Start | End |
---|---|---|---|
Respiratorius AB
Respiratorius AB Pharmaceuticals: MajorHealth Technology Respiratorius AB engages in the development of drug candidates for Chronic Obstructive Pulmonary Disease, asthma, and cancer. The company was founded by Lars Christer Fedrik Fåhraeus and Staffan Skogwall in 1999 and is headquartered in Lund, Sweden. | Director/Board Member | 01/01/2012 | - |
Chief Executive Officer | 01/01/2012 | - | |
Diaprost AB
Diaprost AB Miscellaneous Commercial ServicesCommercial Services Diaprost AB is a private pharmaceutical research and development company based in Lund, Sweden. Diaprost collaborates with leading international experts in the fields of molecular medicine, biotechnology, immunology, radiology, radiation physics, laboratory medicine, and oncology. The Swedish company has an agreement with a top 10 pharma company for its first antibody H11B6 targeting the HK2 antigen, which is in early clinical development. The remaining Diaprost pipeline consists of 5A10, which targets free-PSA antigen for both diagnostic and therapeutic applications. The company was founded in 2005 with the aim of leveraging the transformative success of the PSA assay for detection of prostate cancer as a personalized theranostic platform. Johan Drott has been the CEO of the company since 2015. | Chief Executive Officer | 01/03/2015 | - |
Career history of Johan Drott
Former positions of Johan Drott
Companies | Position | Start | End |
---|---|---|---|
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Chief Executive Officer | 01/07/2018 | 01/12/2018 |
Gambro AB
Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Corporate Officer/Principal | - | - |
Valcuria AB
Valcuria AB Miscellaneous Commercial ServicesCommercial Services Valcuria AB engages in scientific and technical research and development. The private company is based in Lund, Sweden. The Swedish company was founded by Kristina Drott, Johan Drott. | Chief Executive Officer | - | - |
Founder | - | - | |
University of Lund | Corporate Officer/Principal | - | - |
Statistics
International
Sweden | 7 |
Operational
Chief Executive Officer | 4 |
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Sectoral
Health Technology | 4 |
Commercial Services | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
Health Technology |
Private companies | 4 |
---|---|
Gambro AB
Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Health Technology |
Valcuria AB
Valcuria AB Miscellaneous Commercial ServicesCommercial Services Valcuria AB engages in scientific and technical research and development. The private company is based in Lund, Sweden. The Swedish company was founded by Kristina Drott, Johan Drott. | Commercial Services |
Diaprost AB
Diaprost AB Miscellaneous Commercial ServicesCommercial Services Diaprost AB is a private pharmaceutical research and development company based in Lund, Sweden. Diaprost collaborates with leading international experts in the fields of molecular medicine, biotechnology, immunology, radiology, radiation physics, laboratory medicine, and oncology. The Swedish company has an agreement with a top 10 pharma company for its first antibody H11B6 targeting the HK2 antigen, which is in early clinical development. The remaining Diaprost pipeline consists of 5A10, which targets free-PSA antigen for both diagnostic and therapeutic applications. The company was founded in 2005 with the aim of leveraging the transformative success of the PSA assay for detection of prostate cancer as a personalized theranostic platform. Johan Drott has been the CEO of the company since 2015. | Commercial Services |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
- Stock Market
- Insiders
- Johan Drott
- Experience